Glaucoma is a progressive optic neuropathy associated with increased intraocular pressure (IOP; normal range 8-22 mm Hg), which is the only disease-related factor that can be modified. Topical drugs that lower IOP are the first line of treatment for open-angle glaucoma.
CHOICE OF TOPICAL DRUGS — For initial treatment, topical prostaglandin analog (PGA) monotherapy is preferred. If the PGA lowers IOP into the target range, no additional treatment is necessary. If it substantially decreases IOP but falls short of achieving the target range, another topical drug, such as a beta blocker or a carbonic anhydrase...
- A Fixed-Dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine
- In Brief: Epinephrine 1 mg Nasal Spray (neffy)
- In Brief: A New Indication for Tenecteplase (TNKase)
- Diazoxide Choline (Vykat XR) for Prader-Willi Syndrome-Associated Hyperphagia (online only)
- Revakinagene Taroretcel (Encelto) – A Gene Therapy for Idiopathic Macular Telangiectasia (online only)
- Penmenvy — A Second Pentavalent Meningococcal Vaccine
- Benzgalantamine (Zunveyl) for Alzheimer's Disease
- Palopegteriparatide (Yorvipath) for Hypoparathyroidism
- In Brief: Label Changes for Testosterone Products
- In Brief: New Labeling for Once-Monthly Subcutaneous Buprenorphine (Sublocade)
- In Brief: Once-Monthly Lecanemab (Leqembi) for Alzheimer's Disease
- Mirdametinib (Gomekli) for Neurofibromatosis Type 1 (online only)
- Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor (online only)
RELEASE
Miudella (Sebela), a copper intrauterine device (IUD), has been approved by the FDA for prevention of pregnancy for up to 3 years. Miudella is the second copper IUD to be approved in the US; ParaGard, which contains more copper and is approved for up to 10 years of use, was approved in 1984. Four hormonal IUDs (Mirena, Liletta, Skyla, Kyleena) that release the progestin levonorgestrel are also available for pregnancy prevention (see Table 2).1
IUDs — IUDs are highly effective in preventing pregnancy. Once inserted, they provide long-term contraception and require no adherence other than an office visit for replacement. Fertility returns rapidly upon removal. IUDs are considered safe for use in most women, including adolescents and nulliparous women. They do not protect against sexually transmitted infection (STIs).2,3
THE NEW …